| Deler fremragende | 9,348,201 shares |
| Insideraktier | 10.181.989 shares |
| Total Insiders | 37 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Adicet Bio, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Stewart Abbot | 80.000 | ||
| Blake Aftab Chief Scientific Officer - [O] | 2.981 | 2.981 | |
|
Erez Chimovits
Director, 10% Owner -
[D]
|
396.657 | 60.146 | |
| Jeffrey Chodakewitz Director - [D] | 17.700 | 1.106 | |
| Steve Dubin Director - [D] | 22.700 | 1.419 | |
| Fonteyne Paul R. | 14.414 | ||
|
Carl L Gordon
Director, 10% Owner -
[D]
|
11.458.940 | 716.184 | |
| Francesco Galimi SVP & Chief Medical Officer - [O] | 101.801 | 6.363 | |
| Michael Grissinger | 14.414 | ||
| Brian Nicholas Harvey Chief Financial Officer - [O] | 5.145 | 5.145 | |
| Don Healey Chief Technology Officer - [O] | 3.452 | 3.452 | |
| Aya Jakobovits Director - [D] | 862.562 | 53.910 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Michael Kauffman Director - [D] | 5.900 | 369 | |
| Lloyd Klickstein Director - [D] | 108.566 | 6.785 | |
| Carrie Krehlik | 40.000 | ||
| John J Mccabe Vice President, Finance - [O] | 12.867 | 12.867 | |
| Joan Mannick Chief Medical Officer - [O] | 1.404.585 | 1.404.585 | |
| Meredith Manning | 26.000 | ||
|
Orbimed Advisors Llc
10% Owner -
|
0 | 0 | |
| Advisors Israel II Ltd OrbiMed Director - [D] | 242.285 | 0 | |
|
OrbiMed Capital GP V LLC
Director, 10% Owner -
[D]
|
242.285 | 0 | |
|
OrbiMed Capital GP VI LLC
Director, 10% Owner -
[D]
|
242.285 | 0 | |
|
OrbiMed Genesis GP LLC
Director, 10% Owner -
[D]
|
242.285 | 0 | |
| OrbiMed Israel BioFund GP Limited Partnership Director - [D] | 242.285 | 0 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| OrbiMed Israel GP II, L.P. Director - [D] | 242.285 | 0 | |
| OrbiMed Israel GP Ltd. Director - [D] | 242.285 | 0 | |
| Katie Peng Director - [D] | 11.800 | 738 | |
|
PureTech Health LLC
10% Owner -
|
2.119.696 | 2.119.696 | |
|
Ra Capital Management, Llc
10% Owner -
|
932.624 | 932.624 | |
|
Jonathan Silverstein
Director, 10% Owner -
[D]
|
4.830.387 | 4.830.387 | |
| Bastiano Sanna Director - [D] | 5.900 | 369 | |
| Yair Chaim Schindel Director - [D] | 1.104.460 | 69.029 | |
| Chen Schor President & CEO, Director - [D] [O] | 12.875 | 12.875 | |
| Andrew Sinclair Director - [D] | 17.700 | 1.106 | |
| David Adam Steinberg | 14.414 | ||
| Lynne Marie Sullivan | 14.414 | ||
| Daphne Zohar | 0 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACET / Adicet Bio, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACET / Adicet Bio, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | 2026-04-27 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ACET | Common Stock | I | -250.000 | 932.624 | ||||||
| 2026-04-13 | 2026-02-20 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ACET | Common Stock | I | 7,2700 | 74.751 | 543 | 1.182.624 | ||||
| 2026-04-13 | 2026-02-19 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ACET | Common Stock | I | 7,2100 | 74.268 | 535 | 1.107.873 | ||||
| 2026-04-13 | 2026-02-18 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ACET | Common Stock | I | 7,0400 | 74.577 | 525 | 1.033.605 | ||||
| 2026-04-13 | 3 | RA CAPITAL MANAGEMENT, LLC See footnotes | ACET | Common Stock | I | 959.028 | ||||||||
| 2026-04-09 | 2026-04-08 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 6,5200 | -40.416 | -264 | 0 | ||||
| 2026-04-09 | 2026-04-08 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 6,2900 | -32.523 | -205 | 0 | ||||
| 2026-04-09 | 2026-04-07 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 6,3800 | -2.400 | -15 | 32.523 | ||||
| 2026-04-09 | 2026-04-07 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 6,5300 | -29.319 | -191 | 34.923 | ||||
| 2026-01-27 | 2026-01-24 | 4 | Aftab Blake | ACET | Common Stock | D | 8,4400 | -535 | -5 | 2.981 | ||||
| 2026-01-27 | 2026-01-24 | 4 | Healey Don | ACET | Common Stock | D | 8,4400 | -535 | -5 | 3.452 | ||||
| 2026-01-27 | 2026-01-24 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 8,4400 | -546 | -5 | 5.145 | ||||
| 2026-01-27 | 2026-01-24 | 4 | Schor Chen | ACET | Common Stock | D | 8,4400 | -1.755 | -15 | 6.820 | ||||
| 2025-10-10 | 2025-10-08 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 1,0000 | 3.500.000 | 3.500 | 4.490.254 | ||||
| 2025-10-10 | 2025-10-08 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 1,0000 | 1.500.000 | 1.500 | 9.026.359 | ||||
| 2025-06-13 | 2025-06-11 | 4 | Klickstein Lloyd | ACET | Common Stock | D | 5.900 | 108.566 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | Chodakewitz Jeffrey | ACET | Common Stock | D | 5.900 | 17.700 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | DUBIN STEVE | ACET | Common Stock | D | 5.900 | 22.700 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | Peng Katie | ACET | Common Stock | D | 5.900 | 11.800 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | Sinclair Andrew | ACET | Common Stock | D | 5.900 | 17.700 | ||||||
| 2025-01-28 | 2025-01-24 | 4 | Schor Chen | ACET | Common Stock | D | 0,9218 | -28.101 | -26 | 137.201 | ||||
| 2025-01-28 | 2025-01-24 | 4 | Healey Don | ACET | Common Stock | D | 0,9218 | -8.560 | -8 | 63.769 | ||||
| 2025-01-28 | 2025-01-24 | 4 | Aftab Blake | ACET | Common Stock | D | 0,9218 | -6.270 | -6 | 56.241 | ||||
| 2025-01-28 | 2025-01-24 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 0,9218 | -8.752 | -8 | 91.048 | ||||
| 2024-08-20 | 3 | Klickstein Lloyd | ACET | Common Stock | D | 102.666 | ||||||||
| 2024-06-07 | 2024-06-05 | 4 | GORDON CARL L | ACET | Common Stock | D | 5.900 | 11.800 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Chodakewitz Jeffrey | ACET | Common Stock | D | 5.900 | 11.800 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | DUBIN STEVE | ACET | Common Stock | D | 5.900 | 16.800 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Jakobovits Aya | ACET | Common Stock | D | 5.900 | 11.800 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Kauffman Michael | ACET | Common Stock | D | 1,4300 | -5.900 | -8 | 5.900 | ||||
| 2024-06-07 | 2024-06-05 | 4 | Kauffman Michael | ACET | Common Stock | D | 5.900 | 11.800 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Peng Katie | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Sinclair Andrew | ACET | Common Stock | D | 5.900 | 11.800 | ||||||
| 2024-01-26 | 2024-01-25 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 2,4000 | 1.041.700 | 2.500 | 1.255.985 | ||||
| 2024-01-26 | 2024-01-25 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 2,4000 | 242.200 | 581 | 990.254 | ||||
| 2024-01-26 | 2024-01-25 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 2,4000 | 1.841.100 | 4.419 | 7.526.359 | ||||
| 2024-01-26 | 2024-01-25 | 4 | GORDON CARL L See footnotes | ACET | Common Stock | I | 2,4000 | 1.041.700 | 2.500 | 1.255.985 | ||||
| 2024-01-26 | 2024-01-25 | 4 | GORDON CARL L See footnotes | ACET | Common Stock | I | 2,4000 | 242.200 | 581 | 990.254 | ||||
| 2024-01-26 | 2024-01-25 | 4 | GORDON CARL L See footnotes | ACET | Common Stock | I | 2,4000 | 1.841.100 | 4.419 | 7.526.359 | ||||
| 2024-01-26 | 2024-01-24 | 4 | Galimi Francesco | ACET | Common Stock | D | 26.300 | 101.801 | ||||||
| 2024-01-26 | 2024-01-24 | 4 | Galimi Francesco | ACET | Common Stock | D | 2,4000 | -4.957 | -12 | 75.501 | ||||
| 2024-01-26 | 2024-01-24 | 4 | Aftab Blake | ACET | Common Stock | D | 19.700 | 62.511 | ||||||
| 2024-01-26 | 2024-01-24 | 4 | Aftab Blake | ACET | Common Stock | D | 2,4000 | -3.565 | -9 | 42.811 | ||||
| 2024-01-26 | 2024-01-24 | 4 | Healey Don | ACET | Common Stock | D | 19.700 | 72.329 | ||||||
| 2024-01-26 | 2024-01-24 | 4 | Healey Don | ACET | Common Stock | D | 2,4000 | -4.870 | -12 | 52.629 | ||||
| 2024-01-26 | 2024-01-24 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 26.300 | 99.800 | ||||||
| 2024-01-26 | 2024-01-24 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 2,4000 | -4.320 | -10 | 73.500 | ||||
| 2024-01-26 | 2024-01-24 | 4 | Schor Chen | ACET | Common Stock | D | 70.300 | 208.771 | ||||||
| 2024-01-26 | 2024-01-24 | 4 | Schor Chen | ACET | Common Stock | D | 2,4000 | -15.290 | -37 | 138.471 | ||||
| 2023-10-16 | 2023-10-12 | 4 | Aftab Blake | ACET | Common Stock | D | 1,3500 | -7.933 | -11 | 46.376 | ||||
| 2023-10-03 | 2023-10-02 | 4 | Galimi Francesco | ACET | Common Stock | D | 1,3700 | -8.093 | -11 | 80.458 | ||||
| 2023-10-03 | 2023-10-02 | 4 | Healey Don | ACET | Common Stock | D | 1,3700 | -9.069 | -12 | 57.499 | ||||
| 2023-10-03 | 2023-10-02 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 1,3700 | -7.096 | -10 | 77.820 | ||||
| 2023-10-02 | 2023-10-02 | 4 | Schor Chen | ACET | Common Stock | D | 1,3700 | -23.208 | -32 | 153.761 | ||||
| 2023-10-02 | 2023-10-02 | 4 | Schor Chen | ACET | Common Stock | I | 1,3345 | 5.500 | 7 | 43.469 | ||||
| 2023-10-02 | 2023-09-29 | 4 | Schor Chen | ACET | Common Stock | D | 1,3601 | -5.500 | -7 | 176.969 | ||||
| 2023-10-02 | 2023-09-28 | 4 | Schor Chen | ACET | Common Stock | D | 1,4200 | 5.500 | 8 | 182.469 | ||||
| 2023-10-02 | 2023-09-28 | 4 | Schor Chen | ACET | Common Stock | I | 1,4200 | -5.500 | -8 | 37.969 | ||||
| 2023-06-30 | 2023-06-30 | 4 | DUBIN STEVE | ACET | Common Stock | D | 2,3999 | 5.000 | 12 | 10.900 | ||||
| 2023-06-29 | 2023-06-27 | 4 | GORDON CARL L See footnotes | ACET | Common Stock | I | 2,0900 | 58.000 | 121 | 748.054 | ||||
| 2023-06-29 | 2023-06-27 | 4 | GORDON CARL L See footnotes | ACET | Common Stock | I | 2,0900 | 442.000 | 924 | 5.685.259 | ||||
| 2023-06-29 | 2023-06-27 | 4 | GORDON CARL L See footnotes | ACET | Common Stock | I | 2,0900 | 250.000 | 522 | 646.657 | ||||
| 2023-06-29 | 2023-06-27 | 4 | GORDON CARL L See footnotes | ACET | Common Stock | I | 2,0900 | 125.000 | 261 | 1.027.885 | ||||
| 2023-06-29 | 2023-06-27 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 2,0900 | 58.000 | 121 | 748.054 | ||||
| 2023-06-29 | 2023-06-27 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 2,0900 | 442.000 | 924 | 5.685.259 | ||||
| 2023-06-29 | 2023-06-27 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 2,0900 | 250.000 | 522 | 646.657 | ||||
| 2023-06-29 | 2023-06-27 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 2,0900 | 125.000 | 261 | 1.027.885 | ||||
| 2023-06-02 | 2023-06-01 | 4 | Chodakewitz Jeffrey | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | Jakobovits Aya | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | Kauffman Michael | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | Sanna Bastiano | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | DUBIN STEVE | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | GORDON CARL L | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | Sinclair Andrew | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2023-02-17 | 2023-02-15 | 4 | Healey Don | ACET | Common Stock | D | 7,5726 | -4.533 | -34 | 66.568 | ||||
| 2023-02-14 | 2022-11-14 | 5 | Schor Chen | ACET | Common Stock | D | 9.955 | 48.000 | ||||||
| 2023-02-14 | 2022-11-14 | 5 | Schor Chen | ACET | Common Stock | I | -9.955 | 43.469 | ||||||
| 2023-02-14 | 2022-10-17 | 5 | Schor Chen | ACET | Common Stock | I | 26.712 | 53.424 | ||||||
| 2023-02-14 | 2022-10-17 | 5 | Schor Chen | ACET | Common Stock | D | -26.712 | 38.045 | ||||||
| 2023-02-14 | 2022-09-28 | 5 | Schor Chen | ACET | Common Stock | I | 26.712 | 26.712 | ||||||
| 2023-02-14 | 2022-09-28 | 5 | Schor Chen | ACET | Common Stock | D | -26.712 | 64.757 | ||||||
| 2023-02-14 | 2022-09-27 | 5 | Schor Chen | ACET | Common Stock | D | 26.712 | 91.469 | ||||||
| 2023-02-14 | 2022-09-27 | 5 | Schor Chen | ACET | Common Stock | I | -26.712 | 0 | ||||||
| 2023-02-14 | 2022-09-13 | 5 | Schor Chen | ACET | Common Stock | I | 26.712 | 26.712 | ||||||
| 2023-02-14 | 2022-09-13 | 5 | Schor Chen | ACET | Common Stock | D | -26.712 | 64.757 | ||||||
| 2023-02-14 | 2023-02-10 | 4 | Healey Don | ACET | Common Stock | D | 7,9752 | -10.467 | -83 | 71.101 | ||||
| 2023-01-26 | 2023-01-24 | 4 | Schor Chen | ACET | Common Stock | D | 85.500 | 176.969 | ||||||
| 2023-01-26 | 2023-01-24 | 4 | Aftab Blake | ACET | Common Stock | D | 26.100 | 54.309 | ||||||
| 2023-01-26 | 2023-01-24 | 4 | Galimi Francesco | ACET | Common Stock | D | 26.100 | 88.551 | ||||||
| 2023-01-26 | 2023-01-24 | 4 | Healey Don | ACET | Common Stock | D | 26.100 | 81.568 | ||||||
| 2023-01-26 | 2023-01-24 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 26.100 | 84.916 | ||||||
| 2022-11-15 | 2022-11-10 | 4 | Schor Chen | ACET | Common Stock | I | 20,0640 | -30.000 | -602 | 53.424 | ||||
| 2022-11-15 | 2022-11-10 | 4 | Schor Chen | ACET | Common Stock | D | 21,0268 | -9.955 | -209 | 91.469 | ||||
| 2022-11-15 | 2022-11-10 | 4 | Aftab Blake | ACET | Common Stock | D | 21,0000 | -6.967 | -146 | 28.209 | ||||
| 2022-11-09 | 2022-11-07 | 4 | Schor Chen | ACET | Common Stock | I | 19,0496 | -30.000 | -571 | 83.424 | ||||
| 2022-11-04 | 2022-11-03 | 4 | Schor Chen | ACET | Common Stock | I | 18,0437 | -24.813 | -448 | 113.424 | ||||
| 2022-11-04 | 2022-11-02 | 4 | Schor Chen | ACET | Common Stock | I | 18,0000 | -500 | -9 | 138.237 | ||||
| 2022-10-21 | 2022-10-19 | 4 | Aftab Blake | ACET | Common Stock | D | 16,2700 | -8.067 | -131 | 35.176 | ||||
| 2022-10-14 | 2022-10-13 | 4 | Aftab Blake | ACET | Common Stock | D | 15,9200 | -7.933 | -126 | 43.243 | ||||
| 2022-10-14 | 2022-10-12 | 4 | Aftab Blake | ACET | Common Stock | D | 15,4000 | -1.646 | -25 | 51.176 | ||||
| 2022-10-14 | 2022-10-12 | 4 | Aftab Blake | ACET | Common Stock | D | 7,3800 | 3.388 | 25 | 52.822 | ||||
| 2022-10-04 | 2022-10-04 | 4 | Schor Chen | ACET | Common Stock | D | 14,2200 | -21.288 | -303 | 101.424 | ||||
| 2022-10-04 | 2022-10-04 | 4 | Healey Don | ACET | Common Stock | D | 14,2200 | -7.933 | -113 | 55.468 | ||||
| 2022-10-04 | 2022-10-04 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 14,2200 | -7.096 | -101 | 58.816 | ||||
| 2022-10-04 | 2022-10-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 14,2200 | -7.933 | -113 | 62.451 | ||||
| 2022-09-16 | 2022-09-14 | 4 | Schor Chen | ACET | Common Stock | I | 18,0000 | -952 | -17 | 138.737 | ||||
| 2022-09-13 | 2022-09-13 | 4 | Schor Chen | ACET | Common Stock | I | 18,0105 | -3.371 | -61 | 139.689 | ||||
| 2022-09-13 | 2022-09-12 | 4 | Schor Chen | ACET | Common Stock | I | 18,0000 | -200 | -4 | 143.060 | ||||
| 2022-09-13 | 2022-09-12 | 4 | Schor Chen | ACET | Common Stock | I | 16,7694 | -66.747 | -1.119 | 0 | ||||
| 2022-09-13 | 2022-09-09 | 4 | Schor Chen | ACET | Common Stock | I | 16,5062 | -8.094 | -134 | 66.747 | ||||
| 2022-08-08 | 2022-08-04 | 4 | Schor Chen | ACET | Common Stock | D | 18,2500 | -21.288 | -389 | 122.712 | ||||
| 2022-08-08 | 2022-08-04 | 4 | Schor Chen | ACET | Common Stock | D | 48.000 | 144.000 | ||||||
| 2022-08-08 | 2022-07-06 | 4 | Schor Chen | ACET | Common Stock | I | 53.424 | 143.260 | ||||||
| 2022-08-08 | 2022-07-06 | 4 | Schor Chen | ACET | Common Stock | D | -53.424 | 96.000 | ||||||
| 2022-08-08 | 2022-08-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 18,2500 | -5.533 | -101 | 70.384 | ||||
| 2022-08-08 | 2022-08-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 16.000 | 75.917 | ||||||
| 2022-08-08 | 2022-08-04 | 4 | Aftab Blake | ACET | Common Stock | D | 18,2500 | -5.533 | -101 | 49.434 | ||||
| 2022-08-08 | 2022-08-04 | 4 | Aftab Blake | ACET | Common Stock | D | 16.000 | 54.967 | ||||||
| 2022-08-08 | 2022-08-04 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 18,2500 | -4.696 | -86 | 65.912 | ||||
| 2022-08-08 | 2022-08-04 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 16.000 | 70.608 | ||||||
| 2022-08-08 | 2022-08-04 | 4 | Healey Don | ACET | Common Stock | D | 18,2500 | -5.533 | -101 | 63.401 | ||||
| 2022-08-08 | 2022-08-04 | 4 | Healey Don | ACET | Common Stock | D | 16.000 | 68.934 | ||||||
| 2022-08-05 | 2022-08-03 | 4 | Aftab Blake | ACET | Common Stock | D | 18,0000 | -6.968 | -125 | 38.967 | ||||
| 2022-08-03 | 2022-08-01 | 4 | Aftab Blake | ACET | Common Stock | D | 16,6400 | -6.968 | -116 | 45.935 | ||||
| 2022-07-07 | 2022-07-05 | 4 | Aftab Blake | ACET | Common Stock | D | 14,5000 | -1.363 | -20 | 52.903 | ||||
| 2022-05-12 | 2022-05-10 | 4 | Aftab Blake | ACET | Stock Option (Right to Buy) | D | 12,18 | 60.000 | 60.000 | |||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Employee Stock Option (Right to Buy) | D | 16,82 | -1.775 | 26.625 | |||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Employee Stock Option (Right to Buy) | D | 5,97 | -168 | 113.652 | |||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Employee Stock Option (Right to Buy) | D | 13,27 | -6.036 | 73.964 | |||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 21,0000 | -1.775 | -37 | 59.917 | ||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 16,8200 | 1.775 | 30 | 61.692 | ||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 21,0000 | -168 | -4 | 59.917 | ||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 5,9700 | 168 | 1 | 60.085 | ||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 21,0000 | -6.036 | -127 | 59.917 | ||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 13,2700 | 6.036 | 80 | 65.953 | ||||
| 2022-04-05 | 2022-04-01 | 4 | Galimi Francesco | ACET | Employee Stock Option (Right to Buy) | D | 5,97 | -7.621 | 113.820 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Galimi Francesco | ACET | Common Stock | D | 21,0000 | -7.621 | -160 | 59.917 | ||||
| 2022-04-05 | 2022-04-01 | 4 | Galimi Francesco | ACET | Common Stock | D | 5,9700 | 7.621 | 45 | 67.538 | ||||
| 2022-03-11 | 2022-03-09 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,0000 | -2.000 | -28 | 356.345 | ||||
| 2022-03-11 | 2022-03-09 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,0000 | -2.000 | -28 | 356.345 | ||||
| 2022-02-17 | 2022-02-16 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,8319 | -2.000 | -30 | 358.345 | ||||
| 2022-02-17 | 2022-02-16 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,8319 | -2.000 | -30 | 358.343 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Healey Don | ACET | Common Stock | D | 14,2700 | -5.533 | -79 | 52.934 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Healey Don | ACET | Common Stock | D | 16.000 | 58.467 | ||||||
| 2022-02-16 | 2022-02-14 | 4 | Aftab Blake | ACET | Common Stock | D | 14,2700 | -5.533 | -79 | 52.903 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Aftab Blake | ACET | Common Stock | D | 16.000 | 58.436 | ||||||
| 2022-02-16 | 2022-02-14 | 4 | Galimi Francesco | ACET | Common Stock | D | 14,2700 | -5.533 | -79 | 59.917 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Galimi Francesco | ACET | Common Stock | D | 16.000 | 65.450 | ||||||
| 2022-02-16 | 2022-02-14 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 14,2700 | -4.696 | -67 | 54.608 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 16.000 | 59.304 | ||||||
| 2022-02-16 | 2022-02-14 | 4 | Schor Chen | ACET | Common Stock | D | 14,2700 | -21.288 | -304 | 149.424 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Schor Chen | ACET | Common Stock | D | 48.000 | 170.712 | ||||||
| 2022-02-14 | 2022-02-09 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,0303 | -4.000 | -56 | 360.345 | ||||
| 2022-02-14 | 2022-02-09 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,0294 | -4.000 | -56 | 360.343 | ||||
| 2022-02-14 | 2022-01-05 | 4 | Jakobovits Aya | ACET | Common Stock | I | 16,8995 | -2.000 | -34 | 364.345 | ||||
| 2022-02-14 | 2022-01-05 | 4 | Jakobovits Aya | ACET | Common Stock | I | 16,9320 | -2.000 | -34 | 364.343 | ||||
| 2022-02-14 | 2022-01-03 | 4 | Jakobovits Aya | ACET | Common Stock | I | 18,0218 | -6.000 | -108 | 366.345 | ||||
| 2022-02-14 | 2022-01-03 | 4 | Jakobovits Aya | ACET | Common Stock | I | 18,0208 | -6.000 | -108 | 366.343 | ||||
| 2022-02-14 | 2021-12-23 | 5 | Jakobovits Aya | ACET | Common Stock | I | 39.792 | 372.345 | ||||||
| 2022-02-14 | 2021-12-23 | 5 | Jakobovits Aya | ACET | Common Stock | I | 39.791 | 372.343 | ||||||
| 2022-02-14 | 2021-12-23 | 5 | Jakobovits Aya | ACET | Common Stock | I | 29.905 | 138.076 | ||||||
| 2022-02-14 | 2021-12-23 | 5 | Jakobovits Aya | ACET | Common Stock | I | -109.488 | 0 | ||||||
| 2022-02-14 | 2021-12-22 | 5 | Jakobovits Aya | ACET | Common Stock | I | 16,0286 | -7.000 | -112 | 332.553 | ||||
| 2022-02-14 | 2021-12-22 | 5 | Jakobovits Aya | ACET | Common Stock | I | 16,0162 | -7.000 | -112 | 332.552 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Galimi Francesco | ACET | Common Stock | D | 11,6900 | -5.533 | -65 | 49.450 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Galimi Francesco | ACET | Common Stock | D | 16.000 | 54.983 | ||||||
| 2022-02-01 | 2022-01-28 | 4 | Healey Don | ACET | Common Stock | D | 11,6900 | -5.533 | -65 | 42.467 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Healey Don | ACET | Common Stock | D | 16.000 | 48.000 | ||||||
| 2022-02-01 | 2022-01-28 | 4 | Aftab Blake | ACET | Common Stock | D | 11,6900 | -5.564 | -65 | 42.436 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Aftab Blake | ACET | Common Stock | D | 16.000 | 48.000 | ||||||
| 2022-02-01 | 2022-01-28 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 11,6900 | -4.696 | -55 | 43.304 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 16.000 | 48.000 | ||||||
| 2022-02-01 | 2022-01-28 | 4 | Schor Chen | ACET | Common Stock | D | 11,6900 | -21.288 | -249 | 122.712 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Schor Chen | ACET | Common Stock | D | 48.000 | 144.000 | ||||||
| 2022-01-11 | 2022-01-07 | 4 | Harvey Brian Nicholas | ACET | Stock Option (Right to Buy | D | 15,52 | 125.000 | 125.000 | |||||
| 2022-01-11 | 2022-01-07 | 4 | Aftab Blake | ACET | Stock Option (Right to Buy) | D | 15,52 | 125.000 | 125.000 | |||||
| 2022-01-11 | 2022-01-07 | 4 | Galimi Francesco | ACET | Stock Option (Right to Buy) | D | 15,52 | 125.000 | 125.000 | |||||
| 2022-01-11 | 2022-01-07 | 4 | Healey Don | ACET | Stock Option (Right to Buy) | D | 15,52 | 125.000 | 125.000 | |||||
| 2022-01-11 | 2022-01-07 | 4 | Schor Chen | ACET | Stock Option (Right to Buy) | D | 15,52 | 295.000 | 295.000 | |||||
| 2021-12-14 | 2021-12-10 | 4 | GORDON CARL L See Footnotes | ACET | Common Stock | I | 14,0000 | 214.285 | 3.000 | 242.285 | ||||
| 2021-12-14 | 2021-12-10 | 4 | ORBIMED ADVISORS LLC See Footnotes | ACET | Common Stock | I | 14,0000 | 214.285 | 3.000 | 242.285 | ||||
| 2021-12-13 | 2021-12-08 | 4/A | Sinclair Andrew | ACET | Common Stock | I | 14,0000 | 500.000 | 7.000 | 2.115.385 | ||||
| 2021-12-10 | 2021-12-08 | 4 | Sinclair Andrew | ACET | Common Stock | I | 14,0000 | 500.000 | 7.000 | 2.140.721 | ||||
| 2021-11-18 | 2021-11-17 | 4 | Kauffman Michael | ACET | Stock Option (right to Buy) | D | 9,39 | 37.000 | 37.000 | |||||
| 2021-10-13 | 2021-10-12 | 4 | Aftab Blake | ACET | Stock Option (right to Buy) | D | 7,38 | 60.000 | 60.000 | |||||
| 2021-10-13 | 2021-10-12 | 4 | Aftab Blake | ACET | Common Stock | D | 80.000 | 80.000 | ||||||
| 2021-10-05 | 2021-10-01 | 4 | Schor Chen | ACET | Common Stock | D | 240.000 | 240.000 | ||||||
| 2021-10-05 | 2021-10-01 | 4 | Galimi Francesco | ACET | Common Stock | D | 80.000 | 86.983 | ||||||
| 2021-10-05 | 2021-10-01 | 4 | Healey Don | ACET | Common Stock | D | 80.000 | 80.000 | ||||||
| 2021-10-05 | 2021-10-01 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 80.000 | 80.000 | ||||||
| 2021-06-21 | 2021-06-16 | 4 | Schor Chen | ACET | Common Stock | I | 10,5334 | -8.982 | -95 | 89.836 | ||||
| 2021-06-21 | 2021-06-16 | 4 | Schor Chen | ACET | Common Stock | I | 10,5334 | -7.484 | -79 | 74.841 | ||||
| 2021-06-17 | 2021-06-15 | 4 | Jakobovits Aya | ACET | Common Stock | I | 11,1565 | -1.923 | -21 | 215.883 | ||||
| 2021-06-17 | 2021-06-15 | 4 | Jakobovits Aya | ACET | Common Stock | I | 11,1565 | -1.924 | -21 | 215.883 | ||||
| 2021-06-14 | 2021-06-11 | 4 | ABBOT STEWART | ACET | Non-Qualified Option (right to buy) | D | 11,75 | 5.000 | 5.000 | |||||
| 2021-06-08 | 2021-06-04 | 4 | Galimi Francesco | ACET | Employee Stock Option (Right to Buy) | D | 5,97 | -6.983 | 121.441 | |||||
| 2021-06-08 | 2021-06-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 5,9700 | 6.983 | 42 | 6.983 | ||||
| 2021-06-07 | 2021-06-03 | 4 | Schor Chen | ACET | Common Stock | I | 12,0551 | -8.982 | -108 | 98.818 | ||||
| 2021-06-07 | 2021-06-03 | 4 | Schor Chen | ACET | Common Stock | I | 12,0551 | -7.484 | -90 | 82.325 | ||||
| 2021-05-21 | 2021-05-19 | 4 | Schor Chen | ACET | Common Stock | I | 13,7277 | -733 | -10 | 107.800 | ||||
| 2021-05-21 | 2021-05-19 | 4 | Schor Chen | ACET | Common Stock | I | 13,4232 | -8.249 | -111 | 108.533 | ||||
| 2021-05-21 | 2021-05-19 | 4 | Schor Chen | ACET | Common Stock | I | 13,7277 | -612 | -8 | 89.809 | ||||
| 2021-05-21 | 2021-05-19 | 4 | Schor Chen | ACET | Common Stock | I | 13,4232 | -6.872 | -92 | 90.421 | ||||
| 2021-05-20 | 2021-05-20 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,2280 | -900 | -13 | 217.806 | ||||
| 2021-05-20 | 2021-05-20 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,2291 | -892 | -13 | 217.807 | ||||
| 2021-05-20 | 2021-05-18 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,0558 | -3.100 | -44 | 218.706 | ||||
| 2021-05-20 | 2021-05-18 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,0527 | -3.108 | -44 | 218.699 | ||||
| 2021-05-14 | 2021-05-12 | 4 | Jakobovits Aya | ACET | Common Stock | I | 13,2409 | -5.000 | -66 | 221.806 | ||||
| 2021-05-14 | 2021-05-12 | 4 | Jakobovits Aya | ACET | Common Stock | I | 13,2256 | -5.000 | -66 | 221.807 | ||||
| 2021-05-07 | 2021-05-05 | 4 | Schor Chen | ACET | Common Stock | I | 14,7006 | -3.670 | -54 | 116.782 | ||||
| 2021-05-07 | 2021-05-05 | 4 | Schor Chen | ACET | Common Stock | I | 13,8957 | -5.312 | -74 | 120.452 | ||||
| 2021-05-07 | 2021-05-05 | 4 | Schor Chen | ACET | Common Stock | I | 14,7006 | -3.058 | -45 | 97.293 | ||||
| 2021-05-07 | 2021-05-05 | 4 | Schor Chen | ACET | Common Stock | I | 13,8957 | -4.426 | -62 | 100.351 | ||||
| 2021-05-04 | 2021-04-30 | 4 | Sinclair Andrew | ACET | Stock Option (Right to Buy) | D | 15,93 | 8.172 | 8.172 | |||||
| 2021-05-04 | 2021-04-30 | 4 | Sinclair Andrew | ACET | Stock Option (Right to Buy) | D | 15,93 | 18.500 | 18.500 | |||||
| 2021-05-04 | 2021-04-30 | 4 | Jakobovits Aya | ACET | Stock Option (Right to Buy) | D | 15,93 | 18.500 | 18.500 | |||||
| 2021-05-04 | 2021-04-30 | 4 | Sanna Bastiano | ACET | Stock Option (Right to Buy) | D | 15,93 | 1.172 | 1.172 | |||||
| 2021-05-04 | 2021-04-30 | 4 | Sanna Bastiano | ACET | Stock Option (Right to Buy) | D | 15,93 | 18.500 | 18.500 | |||||
| 2021-05-04 | 2021-04-30 | 4 | GORDON CARL L | ACET | Stock Option (Right to Buy) | D | 15,93 | 18.500 | 18.500 | |||||
| 2021-05-04 | 2021-04-30 | 4 | DUBIN STEVE | ACET | Stock Option (Right to Buy) | D | 15,93 | 18.500 | 18.500 | |||||
| 2021-05-04 | 2021-04-30 | 4 | Chodakewitz Jeffrey | ACET | Stock Option (Right to Buy) | D | 15,93 | 18.500 | 18.500 | |||||
| 2021-04-22 | 2021-04-20 | 4 | Schor Chen | ACET | Common Stock | I | 12,0051 | -7.484 | -90 | 104.777 | ||||
| 2021-04-22 | 2021-04-20 | 4 | Schor Chen | ACET | Common Stock | I | 12,0051 | -8.982 | -108 | 125.764 | ||||
| 2021-04-08 | 2021-04-06 | 4 | Schor Chen | ACET | Common Stock | I | 13,0390 | -7.484 | -98 | 112.261 | ||||
| 2021-04-08 | 2021-04-06 | 4 | Schor Chen | ACET | Common Stock | I | 13,0390 | -8.982 | -117 | 134.746 | ||||
| 2021-04-01 | 2021-03-30 | 4 | Schor Chen | ACET | Common Stock | I | 13,2200 | -4.500 | -59 | 119.745 | ||||
| 2021-04-01 | 2021-03-30 | 4 | Schor Chen | ACET | Common Stock | I | 13,2200 | -5.400 | -71 | 143.728 | ||||
| 2021-04-01 | 2021-03-30 | 4 | Schor Chen | ACET | Common Stock | I | 12,3000 | -2.984 | -37 | 124.245 | ||||
| 2021-04-01 | 2021-03-30 | 4 | Schor Chen | ACET | Common Stock | I | 12,3000 | -3.582 | -44 | 149.128 | ||||
| 2021-04-01 | 2021-03-16 | 4/A | Schor Chen | ACET | Common Stock | I | 15,6600 | -2.089 | -33 | 127.229 | ||||
| 2021-04-01 | 2021-03-16 | 4/A | Schor Chen | ACET | Common Stock | I | 15,0700 | -2.508 | -38 | 152.710 | ||||
| 2021-04-01 | 2021-03-16 | 4/A | Schor Chen | ACET | Common Stock | I | 15,6600 | -5.395 | -84 | 129.318 | ||||
| 2021-04-01 | 2021-03-16 | 4/A | Schor Chen | ACET | Common Stock | I | 15,0700 | -6.474 | -98 | 155.218 | ||||
| 2021-04-01 | 2021-01-25 | 4/A | Schor Chen | ACET | Common Stock | I | -27.014 | 0 | ||||||
| 2021-04-01 | 2021-01-25 | 4/A | Schor Chen | ACET | Common Stock | I | -19.286 | 0 | ||||||
| 2021-04-01 | 2021-01-22 | 4/A | Schor Chen | ACET | Common Stock | I | -23.570 | 0 | ||||||
| 2021-04-01 | 2021-01-22 | 4/A | Schor Chen | ACET | Common Stock | I | -22.985 | 0 | ||||||
| 2021-04-01 | 2021-01-22 | 4/A | Schor Chen | ACET | Common Stock | D | -26.070 | 0 | ||||||
| 2021-04-01 | 2020-10-23 | 4/A | Schor Chen | ACET | Common Stock | D | -8.649 | 26.070 | ||||||
| 2021-03-18 | 2021-03-16 | 4 | Schor Chen | ACET | Common Stock | I | 15,6600 | -2.089 | -33 | 127.229 | ||||
| 2021-03-18 | 2021-03-16 | 4 | Schor Chen | ACET | Common Stock | I | 15,0700 | -2.508 | -38 | 152.710 | ||||
| 2021-03-18 | 2021-03-16 | 4 | Schor Chen | ACET | Common Stock | I | 15,6600 | -5.395 | -84 | 129.318 | ||||
| 2021-03-18 | 2021-03-16 | 4 | Schor Chen | ACET | Common Stock | I | 15,0700 | -6.474 | -98 | 155.218 | ||||
| 2021-03-18 | 2020-10-23 | 4 | Klickstein Lloyd | ACET | Common Stock | D | -4.957 | 11.931 | ||||||
| 2021-03-18 | 2019-12-06 | 4 | Klickstein Lloyd | ACET | Common Stock | D | -16.888 | 16.888 | ||||||
| 2021-03-16 | 2021-03-02 | 4/A | Sinclair Andrew | ACET | Stock Option (Right to Buy) | D | 15,75 | 28.828 | 28.828 | |||||
| 2021-03-16 | 3/A | Sinclair Andrew | ACET | Common Stock | I | 1.615.385 | ||||||||
| 2021-03-04 | 3 | Sinclair Andrew | ACET | Common Stock | I | 1.640.721 | ||||||||
| 2021-03-04 | 2021-03-02 | 4 | Sinclair Andrew | ACET | Stock Option (Right to Buy) | D | 15,75 | 28.828 | 28.828 | |||||
| 2021-02-18 | 2021-02-12 | 4 | Chimovits Erez See Footnotes | ACET | Common Stock | I | 13,0000 | 104.050 | 1.353 | 396.657 | ||||
| 2021-02-18 | 2021-02-12 | 4 | Chimovits Erez See Footnotes | ACET | Common Stock | I | 13,0000 | 420.299 | 5.464 | 5.243.259 | ||||
| 2021-02-18 | 2021-02-12 | 4 | GORDON CARL L See Footnotes | ACET | Common Stock | I | 13,0000 | 104.050 | 1.353 | 396.657 | ||||
| 2021-02-18 | 2021-02-12 | 4 | GORDON CARL L See Footnotes | ACET | Common Stock | I | 13,0000 | 420.299 | 5.464 | 5.243.259 | ||||
| 2021-02-18 | 2021-02-12 | 4 | ORBIMED ADVISORS LLC See Footnotes | ACET | Common Stock | I | 13,0000 | 104.050 | 1.353 | 396.657 | ||||
| 2021-02-18 | 2021-02-12 | 4 | ORBIMED ADVISORS LLC See Footnotes | ACET | Common Stock | I | 13,0000 | 420.299 | 5.464 | 5.243.259 | ||||
| 2021-02-17 | 2021-02-12 | 4 | ABBOT STEWART | ACET | Stock Option (Right to Buy) | D | 16,82 | 106.900 | 106.900 | |||||
| 2021-02-17 | 2021-02-12 | 4 | Klickstein Lloyd | ACET | Stock Option (Right to Buy) | D | 16,82 | 41.100 | 41.100 | |||||
| 2021-02-17 | 2021-02-12 | 4 | Harvey Brian Nicholas | ACET | Stock Option (Right to Buy) | D | 16,82 | 28.200 | 28.200 | |||||
| 2021-02-17 | 2021-02-12 | 4 | Healey Don | ACET | Stock Option (Right to Buy) | D | 16,82 | 30.400 | 30.400 | |||||
| 2021-02-17 | 2021-02-12 | 4 | Krehlik Carrie | ACET | Stock Option (Right to Buy) | D | 16,82 | 11.200 | 11.200 | |||||
| 2021-02-17 | 2021-02-12 | 4 | Schor Chen | ACET | Stock Option (Right to Buy) | D | 16,82 | 421.600 | 421.600 | |||||
| 2021-02-17 | 2021-02-12 | 4 | Galimi Francesco | ACET | Stock Option (Right to Buy) | D | 16,82 | 28.400 | 28.400 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Harvey Brian Nicholas | ACET | Stock Option (Right to Buy) | D | 13,27 | 90.000 | 90.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | ABBOT STEWART | ACET | Stock Option (Right to Buy) | D | 13,27 | 80.000 | 80.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Schor Chen | ACET | Stock Option (Right to Buy) | D | 13,27 | 240.000 | 240.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Galimi Francesco | ACET | Stock Option (Right to Buy) | D | 13,27 | 80.000 | 80.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Krehlik Carrie | ACET | Stock Option (Right to Buy) | D | 13,27 | 40.000 | 40.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Healey Don | ACET | Stock Option (Right to Buy) | D | 13,27 | 70.000 | 70.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Klickstein Lloyd | ACET | Stock Option (Right to Buy) | D | 13,27 | 80.000 | 80.000 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Sanna Bastiano | ACET | Stock Option (Right to Buy) | D | 12,00 | 28.828 | 28.828 | |||||
| 2020-10-29 | 2020-10-27 | 4 | Healey Don | ACET | Non-Qualified Option (right to buy) | D | 12,23 | 166.605 | 166.605 | |||||
| 2020-10-27 | 2020-10-23 | 4 | Schor Chen | ACET | Common Stock | D | -8.649 | 72.499 | ||||||
| 2020-09-17 | 2020-09-17 | 4 | Schindel Yair Chaim | ACET | Non-Qualified Stock Option (right to buy) | D | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-15 | 4 | Schindel Yair Chaim By aMoon 2 Fund Limited Partnership | ACET | Common Stock | I | 1.104.460 | 1.104.460 | ||||||
| 2020-09-17 | 2020-09-17 | 4 | Klickstein Lloyd | ACET | Stock Option (Right to Buy) | D | 16,11 | 193.027 | 193.027 | |||||
| 2020-09-17 | 2020-09-17 | 4 | Jakobovits Aya | ACET | Non-Qualified Stock Option (right to buy) | D | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-15 | 4 | Jakobovits Aya By grantor retained irrevocable trust. | ACET | Common Stock | I | 77.500 | 77.500 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | Jakobovits Aya By grantor retained irrevocable trust. | ACET | Common Stock | I | 77.500 | 77.500 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | Jakobovits Aya By grantor retained annuity trust. | ACET | Common Stock | I | 135.799 | 135.799 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | Jakobovits Aya By grantor retained annuity trusts. | ACET | Common Stock | I | 627.812 | 627.812 | ||||||
| 2020-09-17 | 2020-09-17 | 4 | DUBIN STEVE | ACET | Stock Option (Right to Buy) | D | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-17 | 4 | Schor Chen | ACET | Stock Option (Right to Buy) | D | 16,11 | 872.111 | 872.111 | |||||
| 2020-09-17 | 2020-09-17 | 4 | Krehlik Carrie | ACET | Incentive Stock Option (right to buy) | D | 16,11 | 40.391 | 40.391 | |||||
| 2020-09-17 | 2020-09-15 | 4 | Krehlik Carrie | ACET | Employee Stock Option (right to buy) | D | 5,97 | 15.450 | 15.450 | |||||
| 2020-09-17 | 2020-09-15 | 4 | Krehlik Carrie | ACET | Employee Stock Option (right to buy) | D | 2,26 | 18.600 | 18.600 | |||||
| 2020-09-17 | 2020-09-17 | 4 | ABBOT STEWART | ACET | Incentive Stock Option (right to buy) | D | 16,11 | 63.751 | 63.751 | |||||
| 2020-09-17 | 2020-09-15 | 4 | ABBOT STEWART | ACET | Employee Stock Option (right to buy) | D | 5,97 | 57.151 | 57.151 | |||||
| 2020-09-17 | 2020-09-15 | 4 | ABBOT STEWART | ACET | Employee Stock Option (right to buy) | D | 2,26 | 84.791 | 84.791 | |||||
| 2020-09-17 | 2020-09-17 | 4 | Chodakewitz Jeffrey | ACET | Stock Option (Right to Buy) | D | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-17 | 4 | Chimovits Erez | ACET | Stock Option (Right to Buy) | D | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-15 | 4 | Chimovits Erez See Footnotes | ACET | Common Stock | I | 292.607 | 292.607 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | Chimovits Erez See Footnotes | ACET | Common Stock | I | 902.885 | 902.855 | ||||||
| 2020-09-17 | 3 | Chimovits Erez | ACET | No securities are beneficially owned | I | 0 | ||||||||
| 2020-09-17 | 2020-09-17 | 4 | ORBIMED ADVISORS LLC | ACET | Stock Option (Right to Buy) | I | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-17 | 4 | ORBIMED ADVISORS LLC | ACET | Stock Option (Right to Buy) | I | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-15 | 4 | ORBIMED ADVISORS LLC See Footnotes | ACET | Common Stock | I | 292.607 | 292.607 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | ORBIMED ADVISORS LLC See Footnotes | ACET | Common Stock | I | 902.885 | 902.855 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | ORBIMED ADVISORS LLC See Footnotes | ACET | Common Stock | I | 4.822.960 | 4.822.960 | ||||||
| 2020-09-17 | 2020-09-17 | 4 | Galimi Francesco | ACET | Incentive Stock Option (right to buy) | D | 16,11 | 77.269 | 77.269 | |||||
| 2020-09-17 | 2020-09-15 | 4 | Galimi Francesco | ACET | Employee Stock Option (right to buy) | D | 5,97 | 128.424 | 128.424 | |||||
| 2020-09-17 | 2020-09-17 | 4 | GORDON CARL L | ACET | Stock Option (Right to Buy) | D | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-15 | 4 | GORDON CARL L See Footnotes | ACET | Common Stock | I | 292.607 | 292.607 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | GORDON CARL L See Footnotes | ACET | Common Stock | I | 902.885 | 902.855 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | GORDON CARL L See Footnotes | ACET | Common Stock | I | 4.822.960 | 4.822.960 | ||||||
| 2020-09-17 | 3 | OrbiMed Israel BioFund GP Limited Partnership | ACET | No securities are beneficially owned | I | 0 | ||||||||
| 2020-09-17 | 3 | GORDON CARL L See Footnotes | ACET | Common stock | I | 690.055 | ||||||||
| 2020-06-05 | 2020-06-03 | 4 | Chodakewitz Jeffrey | TORC | Stock Option (Right to Buy) | D | 2,23 | 14.414 | 14.414 | |||||
| 2020-06-05 | 2020-06-03 | 4 | Steinberg David Adam | TORC | Stock Option (Right to Buy) | D | 2,23 | 14.414 | 14.414 | |||||
| 2020-06-05 | 2020-06-03 | 4 | Sullivan Lynne Marie | TORC | Stock Option (Right to Buy) | D | 2,23 | 14.414 | 14.414 | |||||
| 2020-06-05 | 2020-06-03 | 4 | SILVERSTEIN JONATHAN | TORC | Stock Option (Right to Buy) | D | 2,23 | 14.414 | 14.414 | |||||
| 2020-06-05 | 2020-06-03 | 4 | FONTEYNE PAUL R. | TORC | Stock Option (Right to Buy) | D | 2,23 | 14.414 | 14.414 | |||||
| 2020-06-05 | 2020-06-03 | 4 | Grissinger Michael | TORC | Stock Option (Right to Buy) | D | 2,23 | 14.414 | 14.414 | |||||
| 2019-12-19 | 2019-12-18 | 4 | PureTech Health LLC | TORC | Common Stock | D | 1,2000 | -6.161.531 | -7.394 | 2.119.696 | ||||
| 2019-12-17 | 2019-12-13 | 4 | PureTech Health LLC | TORC | Common Stock | D | 1,2432 | -205.763 | -256 | 8.281.227 | ||||
| 2019-12-12 | 2019-12-12 | 4 | PureTech Health LLC | TORC | Common Stock | D | 1,2499 | -385.884 | -482 | 8.486.990 | ||||
| 2019-12-12 | 2019-12-11 | 4 | PureTech Health LLC | TORC | Common Stock | D | 1,2500 | -59.921 | -75 | 8.872.874 | ||||
| 2019-12-12 | 2019-12-10 | 4 | PureTech Health LLC | TORC | Common Stock | D | 1,2588 | -336.561 | -424 | 8.932.795 | ||||
| 2019-12-06 | 2019-12-06 | 4 | Schor Chen | TORC | Stock Option (Right to Buy) | D | 1,27 | 258.000 | 258.000 | |||||
| 2019-12-06 | 2019-12-06 | 4 | Schor Chen | TORC | Common Stock | D | 344.000 | 669.000 | ||||||
| 2019-12-06 | 2019-12-06 | 4 | Klickstein Lloyd | TORC | Stock Option (Right to Buy) | D | 1,27 | 88.667 | 88.667 | |||||
| 2019-12-06 | 2019-12-06 | 4 | Klickstein Lloyd | TORC | Common Stock | D | 118.222 | 118.222 | ||||||
| 2019-12-06 | 2019-12-06 | 4 | MCCABE JOHN J | TORC | Stock Option (Right to Buy) | D | 1,27 | 16.400 | 16.400 | |||||
| 2019-12-06 | 2019-12-06 | 4 | MCCABE JOHN J | TORC | Common Stock | D | 12.867 | 12.867 | ||||||
| 2019-12-06 | 2019-12-06 | 4 | Mannick Joan | TORC | Stock Option (Right to Buy) | D | 1,27 | 88.667 | 88.667 | |||||
| 2019-12-06 | 2019-12-06 | 4 | Mannick Joan | TORC | Common Stock | D | 118.222 | 1.404.585 | ||||||
| 2019-11-19 | 2019-11-15 | 4 | PureTech Health LLC | TORC | Common Stock | D | 1,2465 | -531.040 | -662 | 9.269.356 | ||||
| 2019-05-15 | 2019-05-13 | 4 | Klickstein Lloyd | TORC | Stock Option (Right to Buy) | D | 8,08 | 295.000 | 295.000 | |||||
| 2019-05-09 | 2019-05-08 | 4 | Steinberg David Adam | TORC | Stock Option (Right to Buy) | D | 7,99 | 14.414 | 14.414 | |||||
| 2019-05-09 | 2019-05-08 | 4 | FONTEYNE PAUL R. | TORC | Stock Option (Right to Buy) | D | 7,99 | 14.414 | 14.414 | |||||
| 2019-05-09 | 2019-05-08 | 4 | Chodakewitz Jeffrey | TORC | Stock Option (Right to Buy) | D | 7,99 | 14.414 | 14.414 | |||||
| 2019-05-09 | 2019-05-08 | 4 | Grissinger Michael | TORC | Stock Option (Right to Buy) | D | 7,99 | 14.414 | 14.414 | |||||
| 2019-05-09 | 2019-05-08 | 4 | SILVERSTEIN JONATHAN | TORC | Stock Option (Right to Buy) | D | 7,99 | 14.414 | 14.414 | |||||
| 2019-05-09 | 2019-05-08 | 4 | Sullivan Lynne Marie | TORC | Stock Option (Right to Buy) | D | 7,99 | 14.414 | 14.414 | |||||
| 2019-02-28 | 2019-02-27 | 4 | MCCABE JOHN J | TORC | Stock Option (Right to Buy) | D | 8,53 | 24.600 | 24.600 | |||||
| 2019-02-28 | 2019-02-27 | 4 | Manning Meredith | TORC | Stock Option (Right to Buy) | D | 8,53 | 26.000 | 26.000 | |||||
| 2019-02-28 | 2019-02-27 | 4 | Schor Chen | TORC | Stock Option (Right to Buy) | D | 8,53 | 214.000 | 214.000 | |||||
| 2019-02-28 | 2019-02-27 | 4 | Mannick Joan | TORC | Stock Option (Right to Buy) | D | 8,53 | 93.000 | 93.000 | |||||
| 2018-12-17 | 2018-10-26 | 4 | Mannick Joan | TORC | Common Stock | I | 600.000 | 600.000 | ||||||
| 2018-12-17 | 2018-10-26 | 4 | Mannick Joan | TORC | Common Stock | D | -600.000 | 1.286.363 | ||||||
| 2018-12-17 | 2018-11-05 | 4 | Schor Chen | TORC | Common Stock | D | -6.000 | 325.000 | ||||||
| 2018-12-17 | 2018-10-15 | 4 | Schor Chen | TORC | Common Stock | I | -25.000 | 943.000 | ||||||
| 2018-12-17 | 2018-10-15 | 4 | Schor Chen | TORC | Common Stock | D | -25.000 | 943.000 | ||||||
| 2018-12-17 | 2018-10-15 | 4 | Schor Chen | TORC | Common Stock | I | -643.000 | 943.000 | ||||||
| 2018-12-17 | 2018-10-15 | 4 | Schor Chen | TORC | Common Stock | D | -593.363 | 356.000 | ||||||
| 2018-12-17 | 2018-07-06 | 4 | Schor Chen | TORC | Common Stock | D | -943.000 | 949.363 | ||||||
| 2018-11-06 | 2018-11-05 | 4 | Grissinger Michael | TORC | Stock Option (Right to Buy) | D | 11,82 | 28.828 | 28.828 | |||||
| 2018-09-18 | 2018-09-17 | 4 | Manning Meredith | TORC | Stock Option (Right to Buy) | D | 13,94 | 175.000 | 175.000 | |||||
| 2018-08-15 | 2018-08-14 | 4 | Chodakewitz Jeffrey | TORC | Stock Option (Right to Buy) | D | 10,42 | 28.828 | 28.828 | |||||
| 2018-04-17 | 2018-04-16 | 4 | Schor Chen | TORC | Common Stock | D | 8,9533 | 2.000 | 18 | 1.892.363 | ||||
| 2018-04-12 | 2018-04-11 | 4 | Schor Chen | TORC | Common Stock | D | 9,3621 | 2.000 | 19 | 1.890.363 | ||||
| 2018-04-11 | 2018-04-10 | 4 | Schor Chen | TORC | Common Stock | D | 8,4574 | 2.000 | 17 | 1.888.363 | ||||
| 2018-03-14 | 2018-03-13 | 4 | MCCABE JOHN J | TORC | Stock Option (Right to Buy) | D | 15,45 | 4.603 | 4.603 | |||||
| 2018-01-30 | 2018-01-30 | 4 | PureTech Health LLC | TORC | Series A Preferred Stock | D | -7.680.700 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | PureTech Health LLC | TORC | Common Stock | D | 15,0000 | 233.333 | 3.500 | 9.800.396 | ||||
| 2018-01-30 | 2018-01-30 | 4 | PureTech Health LLC | TORC | Common Stock | D | 7.680.700 | 9.567.063 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC See Footnotes | TORC | Series B Preferred Stock | I | -1.871.569 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC See Footnotes | TORC | Series A Preferred Stock | I | -2.425.482 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC See Footnotes | TORC | Common Stock | I | 15,0000 | 533.333 | 8.000 | 4.830.387 | ||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC See Footnotes | TORC | Common Stock | I | 1.871.569 | 4.297.054 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC See Footnotes | TORC | Common Stock | I | 2.425.485 | 2.425.485 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | SILVERSTEIN JONATHAN See Footnotes | TORC | Series B Preferred Stock | I | -1.871.569 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | SILVERSTEIN JONATHAN See Footnotes | TORC | Series A Preferred Stock | I | -2.425.482 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | SILVERSTEIN JONATHAN See Footnotes | TORC | Common Stock | I | 15,0000 | 533.333 | 8.000 | 4.830.387 | ||||
| 2018-01-30 | 2018-01-30 | 4 | SILVERSTEIN JONATHAN See Footnotes | TORC | Common Stock | I | 1.871.569 | 4.297.054 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | SILVERSTEIN JONATHAN See Footnotes | TORC | Common Stock | I | 2.425.485 | 2.425.485 | ||||||
| 2018-01-25 | 3 | Mannick Joan | TORC | Common Stock | D | 3.772.726 | ||||||||
| 2018-01-25 | 3 | Mannick Joan | TORC | Common Stock | D | 3.772.726 | ||||||||
| 2018-01-25 | 3 | PureTech Health LLC | TORC | Common Stock | D | 3.772.726 | ||||||||
| 2018-01-25 | 3 | PureTech Health LLC | TORC | Common Stock | D | 3.772.726 | ||||||||
| 2018-01-25 | 3 | Schor Chen | TORC | Common Stock | D | 3.772.726 | ||||||||
| 2018-01-25 | 3 | Schor Chen | TORC | Common Stock | D | 3.772.726 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
